HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Aliskiren

HCID 5493444
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
173334-57-1
Standard SMILES
COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@H](C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC
InChIKey
UXOWGYHJODZGMF-QORCZRPOSA-N
Molecular formula
C30H53N3O6
Average molar mass
551.769 g/mol
Monoisotopic mass
551.39343642

Names & identifiers

Preferred name
Aliskiren
IUPAC
(2S,4S,5S,7S)-5-Amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-{[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-8-methyl-2-(propan-2-yl)nonanamide
English name
Aliskiren
Molecular formula
C30H53N3O6
Molecular weight
551.76

Names & synonyms

CS-201SPP 100RasilezTekturnaCGP60536BCGP 60536AliskirenAliskiren BaseAliskiren (USAN)Aliskiren, >=98%

Database identifiers

CAS
173334-57-1
PubChem CID
5493444
DTXSID
DTXSID40891494
ChEMBL
CHEMBL1639
ChEBI
CHEBI:601027
UNII
502FWN4Q32
EC Number
605-672-4
Nikkaji
J1.947.312K

Properties

Physicochemical properties

Melting point
98 · 98-99 °C
Boiling point
748.4 · 748.4±60.0 °C(Predicted)
Density
1.067 · 1.067±0.06 g/cm3(Predicted)
storage temp.
-20 °C · Inert atmosphere,Store in freezer, under -20°C
solubility
100 mg/mL · DMSO : 100 mg/mL (181.24 mM; Need ultrasonic)
form
Powder
pka
9.49 · 9.49(at 25℃)
color
White to light yellow
InChIKey
UXOWGYHJODZGMF-PPPRLRNRNA-N
SMILES
C(C)(C)(CNC(=O)[C@H](C(C)C)C[C@H](O)[C@@H](N)C[C@@H](C(C)C)CC1C=CC(OC)=C(OCCCOC)C=1)C(N)=O |&1:7,12,14,17,r|
CAS DataBase Reference
173334 · 173334-57-1(CAS DataBase Reference)
FDA UNII
502 FWN4Q32 · 502FWN4Q32
ATC code
9 XA02 · C09XA02
UNSPSC Code
12352200 · 12352200
NACRES
21 · NA.21
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
315 · H315-H319-H335
Precautionary statements
261 · P261-P264-P271-P280-P302+P352-P305+P351+P338
target organs
Respiratory system
WGK Germany
3 · WGK 3
Storage Class
11 · 11 - Combustible Solids
Hazard Classifications

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

wgk
WGK 3
Signal word
Warning
Symbol(GHS)
GHS07
Storage Class
11 - Combustible Solids
target organs
Respiratory system
Hazard statements
H315-H319-H335
Hazard Classifications
Eye Irrit. 2Skin Irrit. 2STOT SE 3
Precautionary statements
P261-P264-P271-P280-P302+P352-P305+P351+P338
Hazardous Substances Data
173334-57-1(Hazardous Substances Data)

Chemistry & industry

Applications · 4 items

DescriptionAliskiren is a first-in-class antihypertensive drug that acts by direct inhibition of renin. It is indicated for oral administration either as monotherapy or in combination with other antihypertensive agents. Renin catalyzes the cleavage of angiotensin to form angiotensin I, the first and the rate-limiting step of the RAAS. The inhibition of renin by aliskiren results in reduced levels of angiotensin I, angiotensin II, and aldosterone, all of which contribute to the antihypertensive effect. RAAS modulators are among some of the most commonly prescribed antihypertensive agents to date.The most common side effect of aliskiren is diarrhea, particularly with doses higher than 300mg daily. Unlike ACE inhibition, direct inhibition of renin does not increase bradykinin levels. Elevated bradykinin levels are thought to be responsible for the angioderma and cough that occur commonly during treatment with ACE inhibitors. .

UsesAn orally active, synthetic nonpeptide renin inhibitor. Antihypertensive

Usesliquid crystal intermediate

General DescriptionAliskiren, (2S,4S,5S,7S)-5-amino-N-(2-carbamoyl-2-methyl-propyl)-4-hydroxy-7-{[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-8-methyl-2-propan-2-yl-nonanamide (Tekturna), is the first renin inhibitorintroduced into the U. S. market. It was approved by theFDA in 2007 for the management of hypertension.The trade name for aliskiren in the United Kingdom isRasilez.

Additional notes

DefinitionChEBI: A monomethoxybenzene compound having a 3-methoxypropoxy group at the 2-position and a multi-substituted branched alkyl substituent at the 4-position.

Related reactions

7 records
New reaction record
HRID 264930 reaction equation
HRID 264930As product
HRID 500016 reaction equation
HRID 500016As product
HRID 725624 reaction equation
HRID 725624As product
HRID 744818 reaction equation
HRID 744818As product
HRID 1686374 reaction equation
HRID 1686374As reactant
HRID 2172656 reaction equation
HRID 2172656As reactant
HRID 2256731 reaction equation
HRID 2256731As product

Compound notes

On this pageBasic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
2 Skin · Eye Irrit. 2Skin Irrit. 2STOT SE 3
Hazardous Substances Data
173334 · 173334-57-1(Hazardous Substances Data)